Literature DB >> 26178599

Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descent.

Marije K Verheul1, Kazuko Shiozawa2, E W Nivine Levarht3, Tom W J Huizinga3, Rene E M Toes3, Leendert A Trouw1, Shunichi Shiozawa4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26178599     DOI： 10.1093/rheumatology/kev250

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

Review 1.  Biomarkers to guide clinical therapeutics in rheumatology?

Authors:  William H Robinson; Rong Mao
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

Review 2.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

3.  Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis.

Authors:  Paschalis Sidiras; Jessica Lechanteur; Virginie Imbault; Tatiana Sokolova; Patrick Durez; Valérie Gangji; David Communi; Joanne Rasschaert
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

4.  Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.

Authors:  Liubing Li; Chuiwen Deng; Si Chen; Shulan Zhang; Ziyan Wu; Chaojun Hu; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

5.  The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.

Authors:  Myrthe A M van Delft; Marije K Verheul; Leonie E Burgers; Veerle F A M Derksen; Annette H M van der Helm-van Mil; Diane van der Woude; Tom W J Huizinga; René E M Toes; Leendert A Trouw
Journal:  Arthritis Res Ther       Date:  2017-08-15       Impact factor: 5.156

Review 6.  From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Shue-Fen Luo; Jenn-Haung Lai
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

7.  Increased Serum Levels of Anti-Carbamylated 78-kDa Glucose-Regulated Protein Antibody in Patients with Rheumatoid Arthritis.

Authors:  Hui-Chun Yu; Pei-Hsuan Lai; Ning-Sheng Lai; Hsien-Bin Huang; Malcolm Koo; Ming-Chi Lu
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

8.  Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor.

Authors:  Maizatul A Othman; Wan Syamimee W Ghazali; Wan Zuraida W A Hamid; Kah K Wong; Nurul K Yahya
Journal:  Saudi Med J       Date:  2017-09       Impact factor: 1.484
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.